COSCIENS Biopharma (ET8.STU) Q1 2026 Earnings

25MarConfirmed
Q2 2025
Q1 2026
-9.53
-9.2
-8.87
-8.53

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

COSCIENS Biopharma (ET8.STU) will report earnings of for Q1 2026 on March 25, 2026.

0 Comments

Share your thoughts